Winnipeg, Manitoba, Canada Richardson Capital appeared to be the VC, which was created in 1857. The company was established in North America in Canada. The main office of represented VC is situated in the Winnipeg.
For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Ventaira Pharmaceuticals. Among the most successful fund investment fields, there are Semiconductor, Pharmaceutical. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The top amount of exits for fund were in 2007. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2003.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Richardson Capital, startups are often financed by Pfizer. The meaningful sponsors for the fund in investment in the same round are TL Ventures, Merlin Biomed, Fletcher Spaght, Inc.. In the next rounds fund is usually obtained by TL Ventures, Safeguard Scientifics, Reservoir Venture Partners.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Carlsquare | Berlin, Berlin, Germany |
| Haitong Hengxin International Leasing | China, Shanghai |
| HuaJin Securities | China, Shanghai |
| IndiaMART | India, Noida, Uttar Pradesh |
| Last Mile Ventures | England, London, United Kingdom |
| Mars Asset | Chengdu, China, Sichuan |
| Milcom Technologies | - |
| Sushi Venture Partners | England, London, United Kingdom |
| Zip Co | Australia, New South Wales, Sydney |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
OptiSolar R&D | $132M | 11 Apr 2008 | Hayward, California, United States | ||
Ventaira Pharmaceuticals | $22M | 20 Feb 2003 | Columbus, Ohio, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
OptiSolar R&D | $132M | 11 Apr 2008 | Hayward, California, United States | ||
Ventaira Pharmaceuticals | $22M | 20 Feb 2003 | Columbus, Ohio, United States |
